Loading resource…

Various institutions including Sapienza University of Rome, University of Athens, Rigshospitalet, Charité Universitätsmedizin Berlin, Erasmus University Medical Center, Newcastle University, Ente Ospedaliero Cantonale, Università della Svizzera italiana
Sodium levothyroxine (LT4) is the primary treatment for hypothyroidism, yet many patients struggle to achieve therapeutic goals. An expert task force from the European Thyroid Association has reviewed existing data to formulate guidelines aimed at optimizing LT4 therapy. The document discusses dosing considerations, particularly in special populations such as obese patients and those who have undergone thyroidectomy, emphasizing the importance of individualized treatment plans.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology

Kiruddu DKA guidelines
Same clinical topic · Endocrinology

Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology

Management of DKA
Same clinical topic · Endocrinology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology

2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology

CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology

Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology